Project Grant HT94252411019
Award Date
9/1/24
Completion Date
8/31/28
Dollars Obligated
$2.6M
Federal Agency
Defense Health Agency
Awardee
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. (UYLKBRENAPG5)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Westlake, MD 20817, USA
Similar Awards
The Department of the Army Medical Command awarded a $4.7 million Project Grant to The Research Foundation for the State University of New York to support the research project "Exercise Reset for Concussion: Modifying the Buffalo Concussion Protocol for Application in a Military Environment" from September 2022 through September 2026. The grant was awarded under the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to improve military...
The Department of the Army Medical Command awarded a $2,289,304.00 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program to The Medical College of Wisconsin, Inc. The grant, with a performance period from August 1, 2024 to July 31, 2027, is funding research to improve in-hospital and post-discharge patient education for mild traumatic brain injury. The grant includes a sub-award to The Ohio State University to support this research initiative....
The Department of the Army Medical Command awarded a $2,008,900 project grant to the Veterans Medical Research Foundation of San Diego under the Military Medical Research and Development program (CFDA 12.420). The four-year project grant will fund research into combined nonpharmacological therapies for mild traumatic brain injury (mTBI)-related headaches from September 2021 through August 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical...
This federal Project Grant award, valued at $1,339,480.00 and awarded on September 30, 2024, was provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research to develop and evaluate the efficacy of a novel, patient-centered physical therapy intervention called SPINEPASS for the treatment of persistent headache following mild traumatic brain injury. The key objectives are to: Establish the efficacy of...
The Department of the Army Medical Command awarded a $1.66 million Project Grant to the University of Utah's Office of Sponsored Projects under the Military Medical Research and Development program (CFDA 12.420). The three-year award will fund research into "Spreading Depolarizations' in the Network Dysfunction Leading to Post-Traumatic Headache." Through September 2021 to August 2024, the grantee will investigate medical solutions for post-traumatic headache on the battlefield and...
This federal Project Grant award of $553,189.00 was issued on September 1, 2025 by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant was awarded to Weill Medical College of Cornell University to conduct research on "CIRCULATING ANTIBODY REPERTOIRE AND BLOOD-BRAIN-BARRIER IMPAIRMENT TO EXPLAIN NEUROPSYCHIATRIC SYMPTOMS OF 'INVISIBLE' BRAIN INJURY". The research aims to transform healthcare for military service members,...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,461,585.00 to Oregon Health & Science University (OHSU) to conduct the research project "MULTIMODAL MRI-BASED ASSESSMENT OF GLYMPHATIC FUNCTION IN CONCUSSED INDIVIDUALS: CLINICAL APPLICATIONS AND ASSOCIATION WITH OUTCOMES". The award period runs from Sep 1, 2025 to Aug 31, 2029. The project aims to utilize advanced multimodal MRI...
This Project Grant award of $856,523.00, awarded by the Defense Health Agency on September 30, 2025, supports the "Military Medical Research and Development" (CFDA 12.420) program. The grant funds advanced biomedical research to transform healthcare for military service members, veterans, and the public, focusing on innovative investigations across medical disciplines such as neuroscience, genetic disorders, and emerging technologies. The awardee, The Henry M. Jackson Foundation for...
The Defense Health Agency awarded a $1,973,398 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Azevan Pharmaceuticals Inc. in Bethlehem, PA. The grant supports the development of a new drug to prevent the effects of mild traumatic brain injury (TBI) or concussion. The research project will be conducted over a 2-year period from June 2024 to June 2026. The goal is to advance the development of an innovative medical solution to address this critical...
This $309,279 Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a research study on traumatic brain injury (TBI) and psychological health conducted by Florida State University. The primary objectives are to adapt the Ohio State University TBI Identification Method and the STAIR-NT intervention for first responders with TBI, analyze the data, and disseminate the study findings. Key sub-award activities...